Try our beta test site
Trial record 1 of 1 for:    NCT01876446
Previous Study | Return to List | Next Study

Pegylated Irinotecan NKTR 102 in Treating Patients With Relapsed Small Cell Lung Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2017 by Roswell Park Cancer Institute
Sponsor:
Collaborators:
National Cancer Institute (NCI)
Nektar Therapeutics
Information provided by (Responsible Party):
Roswell Park Cancer Institute
ClinicalTrials.gov Identifier:
NCT01876446
First received: June 10, 2013
Last updated: March 7, 2017
Last verified: March 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 1, 2018
  Estimated Primary Completion Date: May 1, 2017 (Final data collection date for primary outcome measure)